Addictive Behaviors | Alcohol Addiction, Phase II

Pregnenolone for Alcohol Use Disorder

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this 12-week study is to see if pregnenolone, a naturally occurring hormone, reduces alcohol intake and the desire to use alcohol in individuals with alcohol use disorder. Participation involves weekly or biweekly visits to the Yale Stress Center in New Haven, as well as free weekly counseling sessions.

Total estimated compensation is $1574.

For information contact: Yale Stress Center at 1-877-Y-STRESS(1-888-978-7377) or email: stress@yale.edu

Trial with
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Ages
18 years - 70 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Yale Stress Center

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Verica Milivojevic, PhD
Assistant Professor of Psychiatry; Director of Medication Research Projects, Yale Stress Center; Director, Neuroactive Steroids, Addiction and Stress (NAS) Lab, Department of Psychiatry

Sub-Investigators

Last Updated
07/30/2024
Study HIC
#2000034929